毕业于华中科技大学同济医学院附属协和医院，擅长肿瘤内科治疗和放疗。
从业经历：
1、Wen Q, Zhao K, et al. Mechanism of Inhibition of MYC Protein Expression in Diffuse Large B-cell.(under review) l
2、Wen Q, Li Q, et al. Composite B-cell Lymphoma and Extranodal NK/T-cell Lymphoma Presented Lymphoma by Disulfiram. (under review) with Distinct Clone Evolution and Tumor Microenvironment.(under review) l
3、 Zheng X, Liu Z, Mi M, Wen Q, et al. Disulfiram Improves the Anti-PD-1 Therapy Efficacy by Regulating PD-L1 Expression via Epigenetically Reactivation of IRF7 in Triple Negative Breast Cancer. Front Oncol. 2021 Nov 10;11:734853.(IF=5.738) l
4、Mi M, Liu Z, Zheng X,Wen Q, et al.Serum metabolomic profiling based on GC/MS helped to discriminate Diffuse Large B-cell Lymphoma patients with different prognosis. Leuk Res. 2021Dec;111: 106693.(IF=3.715) l
5、Wen Q, Li X, et al. A new prognostic nomogram in patients with mucosa-associated lymphoid tissue lymphoma:A multicenter retrospective study. Front Oncol.13:1123469.(IF=5.738) (The first author) l
6、Wang T, Wen Q, et al. Percutaneous Gastrostomy Compared with Esophageal Stent Placement for the Treatment of Esophageal Cancer with Dysphagia. J Vasc Interv Radiol. 2021 Aug; 32(8):1215-1220.(IF=3. 682) (Co-first author)
7、文秋月,谭巧云,张利玲.2022年慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的治疗进展[J].中国肿瘤临床与康复, 2020,17(01):13-17.(The first author) l
Zhao K, Wen Q, et al. Identifying oxidative stress key genes associated with prognosis in diffuse large B-cell lymphoma.(under review)
共发表SCI 4篇，双核心期刊1篇。
曾获得医学基金一项:Pin1介导自噬调控肿瘤细胞耐药机制
2、Wen Q, Li Q, et al. Composite B-cell Lymphoma and Extranodal NK/T-cell Lymphoma Presented Lymphoma by Disulfiram. (under review) with Distinct Clone Evolution and Tumor Microenvironment.(under review) l
3、 Zheng X, Liu Z, Mi M, Wen Q, et al. Disulfiram Improves the Anti-PD-1 Therapy Efficacy by Regulating PD-L1 Expression via Epigenetically Reactivation of IRF7 in Triple Negative Breast Cancer. Front Oncol. 2021 Nov 10;11:734853.(IF=5.738) l
4、Mi M, Liu Z, Zheng X,Wen Q, et al.Serum metabolomic profiling based on GC/MS helped to discriminate Diffuse Large B-cell Lymphoma patients with different prognosis. Leuk Res. 2021Dec;111: 106693.(IF=3.715) l
5、Wen Q, Li X, et al. A new prognostic nomogram in patients with mucosa-associated lymphoid tissue lymphoma:A multicenter retrospective study. Front Oncol.13:1123469.(IF=5.738) (The first author) l
6、Wang T, Wen Q, et al. Percutaneous Gastrostomy Compared with Esophageal Stent Placement for the Treatment of Esophageal Cancer with Dysphagia. J Vasc Interv Radiol. 2021 Aug; 32(8):1215-1220.(IF=3. 682) (Co-first author)
7、文秋月,谭巧云,张利玲.2022年慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的治疗进展[J].中国肿瘤临床与康复, 2020,17(01):13-17.(The first author) l
Zhao K, Wen Q, et al. Identifying oxidative stress key genes associated with prognosis in diffuse large B-cell lymphoma.(under review)
共发表SCI 4篇，双核心期刊1篇。
曾获得医学基金一项:Pin1介导自噬调控肿瘤细胞耐药机制
